West Pharmaceutical Services Inc
Slēgts
SektorsVeselības aprūpe
335.99 2
Pārskats
Akcijas cenas izmaiņa
24h
Min
325
Max
336.26
Ienākumi | 6.7M 139M |
|---|---|
Pārdošana | 40M 845M |
P/E Sektora vidējais | 44.079 49.712 |
EPS | 2.13 |
Dividenžu ienesīgums | 0.26 |
Peļņas marža | 16.428 |
Darbinieki | 10,800 |
EBITDA | 9M 219M |
Rekomendācijas | Pirkt (spēcīgs) |
|---|---|
Prognoze 12 mēnešiem | +13.13% upside |
Dividenžu ienesīgums Sektora vidējais | 0.26% 2.36% |
|---|---|
Nākamie ieņēmumi | 2026. g. 23. jūl. |
Nākamais dividenžu datums | 2026. g. 5. aug. |
Nākamais Ex dividenžu datums | 2026. g. 29. jūl. |
Tirgus kapitalizācija | 3.3B 23B |
|---|---|
Iepriekšējā atvēršanas cena | 333.99 |
Iepriekšējā slēgšanas cena | 335.99 |
Ziņu noskaņojums
By Acuity
50%
50%
143 / 342 Rangs Healthcare
West Pharmaceutical Services Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.